Conference Coverage: ESMO 2021 – FOCUS ON GU

Impact of recent ESMO data on clinical practice and therapy guidance in genitourinary cancer

September 22, 2021
Daniel Petrylak, MD, Yale, Aptitude Health


Daniel Petrylak, MD

Yale Cancer Center, New Haven, CT, USA

Faculty Members

Karim Fizazi, MD, PhD
Institute Gustave Roussy, Villejuif, France

Oliver Sartor, MD
Tulane Cancer Center, New Orleans, LA, US

Manuela Schmidinger, MD
Medical University of Vienna, Vienna, Austria

Susan Slovin, MD, PhD
Memorial Sloan Kettering Cancer Center, New York, NY, US

Thomas Powles, MD, MBBS, MRCP
Barts Cancer Institute, London, UK

Scott Tagawa, MD, FACP
Weill Cornell Medical Center, New York, NY, US


Sample Report

Start discovering the insights

View Report


  • Renal Cell Carcinoma
  • Prostate Cancer – Hormonal Therapies, Resistance, and Imaging
  • Cytotoxic, Immune, and Targeted Therapies for Metastatic Prostate Cancer
  • Bladder Cancer

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.